Tumour radiosensitization with the halogenated pyrimidines 5'-bromo- and 5'-iododeoxyuridine.
Epstein
A H
AH
Radiation Oncology Branch, National Cancer Institute, Bethesda, MD 20892.
Cook
J A
JA
Goffman
T
T
Glatstein
E
E
D001932:Brain Neoplasms / Q000532:radiotherapy*; D001973:Bromodeoxyuridine / Q000627:therapeutic use*; D005910:Glioma / Q000532:radiotherapy*; D006258:Head and Neck Neoplasms / Q000532:radiotherapy*; D006801:Humans; D007065:Idoxuridine / Q000627:therapeutic use*; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use*; D012509:Sarcoma / Q000532:radiotherapy*
D011838:Radiation-Sensitizing Agents; D001973:Bromodeoxyuridine; D007065:Idoxuridine